MedPath

ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation

Not Applicable
Conditions
Hepatic Carcinoma
Registration Number
NCT05009550
Lead Sponsor
TC Erciyes University
Brief Summary

To evaluate the ability of Erector spina Plane Block decrease postoperative pain and analgesia requirements in patients undergoing percutaneous Radiofrequency ablation of Hepatocellular Carcinomas.

Detailed Description

Erector spina Plane Block is performed with guided ultrasound at T8 transverse process level lead to adequate intraprocedural and postoperative analgesia, in percutaneous Radiofrequency ablation of Hepatocellular Carcinomas.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • ASA I-II patients
Exclusion Criteria
  • history of allergy to the study medication
  • refused to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Numeric Pain Scale assesment24 hours after procedure

A research assistant, blinded to the group allocation, interviewed patients and collected data at 6 times intervals (0.,2.,4.,6.,12 and 24 hours) in the 24 hours postprocedure. Patients will be asked to rate their pain using Numeric Pain Scale, where 0=no pain and 10=worst pain possible.

Secondary Outcome Measures
NameTimeMethod
Demographic data24 hours after procedure

Age, BMI, ASA, Duration of procedure are recorded.

Incidences of adverse effects (like nausea and vomiting)24 hours after procedure

Incidences of adverse effects (like nausea and vomitting) during the 24 hours postprocedure perİod is recorded at 6 times intervals (0,2,4,6,12,24 hours)

Trial Locations

Locations (1)

Özlem Öz Gergin

🇹🇷

Kayseri, Turkey

Özlem Öz Gergin
🇹🇷Kayseri, Turkey
Özlem Öz Gergin, MD
Contact
09005332466396
oozgergin@erciyes.edu.tr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.